Macro Group Pharmaceuticals (Macro Capital) S.A.E reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EGP 594.26 million compared to EGP 430.5 million a year ago. Net income was EGP 147.93 million compared to EGP 135.13 million a year ago.

Basic earnings per share from continuing operations was EGP 0.26 compared to EGP 0.23 a year ago. Diluted earnings per share from continuing operations was EGP 0.26 compared to EGP 0.23 a year ago.